EDGAR Filing Documents for 0000850261-17-000004

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0000850261-17-000004

Filing Date

2017-08-09

Accepted

2017-08-09 16:41:17

Documents

Period of Report

2017-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q	srne6301710-q.htm	10-Q	1151622
2	EXHIBIT 10.1	ex101.htm	EX-10.1	48624
3	EXHIBIT 10.2	ex102.htm	EX-10.2	50322
4	EXHIBIT 10.4	ex104.htm	EX-10.4	272674
5	EXHIBIT 10.5	ex105.htm	EX-10.5	22588
6	EXHIBIT 10.6	ex106.htm	EX-10.6	17589
7	EXHIBIT 10.7	ex107.htm	EX-10.7	15966
8	EXHIBIT 31.1	srneex311-63017.htm	EX-31.1	10556
9	EXHIBIT 31.2	srneex312-63017.htm	EX-31.2	10508
10	EXHIBIT 32.1	srneex321-63017.htm	EX-32.1	13484
	Complete submission text file	0000850261-17-000004.txt		9185127

Data Files

Seq	Description	Document	Type	Size
11	XBRL INSTANCE DOCUMENT	srne-20170630.xml	EX-101.INS	1587851
12	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	srne-20170630.xsd	EX-101.SCH	79297
13	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT	srne-20170630_cal.xml	EX-101.CAL	92502
14	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT	srne-20170630_def.xml	EX-101.DEF	473124
15	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	srne-20170630_lab.xml	EX-101.LAB	1007165
16	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	srne-20170630_pre.xml	EX-101.PRE	650516

Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121

Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100

Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)